Opportunities and challenges for targeted radionuclide therapy of prostate cancer using 161Tb
Idioma
EN
Article de revue
Este ítem está publicado en
Médecine Nucléaire. 2023-10-05, vol. 47, n° 6, p. 333-338
Resumen en inglés
161Tb has aroused great interest to improve response rate of targeted radionuclide therapy due to its unique decay features. In this review article, decay properties of medically relevant radionuclides of the terbium element ...Leer más >
161Tb has aroused great interest to improve response rate of targeted radionuclide therapy due to its unique decay features. In this review article, decay properties of medically relevant radionuclides of the terbium element are first described. Next, modeling studies, production, preclinical and clinical studies performed using 161Tb in prostate cancer are reviewed.< Leer menos
Palabras clave en inglés
Prostate cancer
Therapy
Proyecto ANR
Initiative d'excellence de l'Université de Bordeaux - ANR-10-IDEX-0003
Centros de investigación